CYTORI THERAPEUTICS, INC. 4
4 · CYTORI THERAPEUTICS, INC. · Filed Jan 4, 2016
Insider Transaction Report
Form 4
RICKEY DAVID
Director
Transactions
- Award
Incentive Stock Option (Right to Buy)
2016-01-04+53,820→ 245,950 totalExp: 2026-01-04→ Common Stock (53,820 underlying)
Footnotes (2)
- [F1]The reporting person received an incentive stock option granted under the Corporation's 2014 Equity Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised shall be the closing sale price of the Corporation's Common Stock on the NASDAQ Stock Market as of the date of the grant. The closing sale price is $0.1872.
- [F2]Fifty percent (50%) of the option shares shall vest on January 4, 2017 with the remaining fifty percent (50%) of the option shares vesting on January 4, 2018.